Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease-A review

Contact Lens and Anterior Eye

Volumn 36, Issue 6, 2013, Pages 272-280

  Doughty, Michael J ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Artificial tears; Dry eye; Keratoconjunctivitis sicca; Lissamine green; Rose bengal

Indexed keywords

ARTIFICIAL TEAR; LUBRICATING AGENT; ROSE BENGAL;

CELL NUCLEUS; CELL POPULATION; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL ASSESSMENT; CONJUNCTIVAL CELL; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRY EYE; EYE DISCOMFORT; EYE INJURY; FOLLOW UP; HUMAN; LISSAMINE GREEN OCULAR SURFACE STAINING; MOLECULAR DYNAMICS; NONHUMAN; OCULAR SURFACE DAMAGE; OCULAR SURFACE DESSICATION; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; REVIEW; SLIT LAMP; STAINING; VITAL STAIN;

ARTIFICIAL TEARS; DRY EYE; KERATOCONJUNCTIVITIS SICCA; LISSAMINE GREEN; ROSE BENGAL;

CORNEA; DRY EYE SYNDROMES; FLUORESCENT DYES; FLUOROPHOTOMETRY; HUMANS; OPHTHALMIC SOLUTIONS; OPHTHALMOSCOPY; PATIENT OUTCOME ASSESSMENT; ROSE BENGAL; STAINING AND LABELING; TREATMENT OUTCOME;

EID: 84886294400     PISSN: 13670484     EISSN: 14765411     Source Type: Journal    
DOI: 10.1016/j.clae.2013.07.008     Document Type: Review

References (88)

1. Lemp M.A. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO Journal 1995, 21:221-232.
2. Doughty M.J., Fonn D., Richter D., Simpson T., Caffery B., Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optometry & Vision Science 1997, 74:624-631.
3. Albietz J.M. Prevalence of dry eye subtypes in clinical optometry practice. Optometry & Vision Science 2000, 77:357-363.
4. Begley C.G., Chalmers R.L., Mitchell G.L., Nichols K.K., Caffery B., Simpson B., et al. Characterization of ocular surface symptoms from optometric practices on North America. Cornea 2001, 20:610-618.
5. Schein O.D., Tielsch J.M., Muñoz B., Bandeen-Roche K., West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997, 104:1395-1401.
6. Aakre B.M., Doughty M.J. Are there differences between visual symptoms' and specific ocular symptoms associated with video display terminal (VDT) use?. Contact Lens Anterior Eye 2007, 30:174-182.
7. Cuevas M., Gonlzález-Garćia M.J., Castellanos E., Quispaya R., De La Parra P., Fernández I., et al. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Current Eye Research 2012, 37:855-863.
8. Doughty M.J. pH-dependent spectral properties of sodium fluorescein ophthalmic solutions revisited. Ophthalmic and Physiological Optics 2010, 30:167-174.
9. Pflugfelder S.C., Solomon A., Stern M.E. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000, 19:644-649.
10. Korb D.R. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000, 19:483-486.
11. Bron A.J., Evans V.E., Smith J.A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003, 22:640-650.
12. Foulks G.N. Challenges and pitfalls in clinical trials of treatment of dry eye. Ocular Surface 2003, 1:20-30.
13. Nichols K.K., Mitchell G.L., Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004, 23:272-285.
14. Doughty M.J., Lee C.-A., Ritchie S., Naase T. An assessment of the discomfort associated with the use of rose Bengal 1% eyedrops on the normal human eye-a comparison with saline 0.9% and a topical ocular anaesthetic. Ophthalmic and Physiological Optics 2007, 27:159-167.
15. Doughty M.J., Hagan S. On the staining of human tissue-cultured (Chang) conjunctival cells with rose bengal and lissamine green. Contact Lens Anterior Eye 2013, 36:32-40.
16. Feenstra R.P.G., Tseng S.C.G. What is actually stained by rose bengal?. Archives of Ophthalmology 1992, 110:984-993.
17. Feenstra R.P.G., Tseng S.C.G. Comparison of fluorescein and rose bengal staining. Ophthalmology 1992, 99:605-617.
18. Tabery H.M. Toxic effect of rose bengal dye on the living human corneal epithelium. Acta Ophthalmologica Scandinavica 1998, 76:142-145.
19. Efron N. Putting vital stains in context. Clinical and Experimental Optometry 2013, 96:400-421.
20. Norn M.S. Method of testing dyes for vital staining of cornea and conjunctiva. Acta Ophthalmologica 1972, 50:809-814.
21. Norn M.S. Lissamine green. Vital staining of cornea and conjunctiva. Acta Ophthalmologica 1973, 51:483-491.
22. Emran N., Sommer A. Lissamine green staining in the clinical diagnosis of xerophthalmia. Archives of Ophthalmology 1979, 97:2333-2335.
23. Kusin J.A., Soewondo W., Sinaga H.S. Rose Bengal and lissamine green vital stains: useful diagnostic aids for early stages of xerophthalmia?. American Journal of Clinical Nutrition 1979, 32:1559-1562.
24. Khurana A.K., Chaudhary R., Ahluwalia B.K., Gupta S. Tear film profile in dry eye. Acta Ophthalmologica 1991, 69:79-86.
25. Manning F.J., Wehrly S.R., Foulks G.W. Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995, 102:1953-1957.
26. Amaki S., Ogata T., Konishi M., Shimizu K., Yamada M., Mashima Y. Lissamine green B staining in the evaluating of keratoconjunctivitis sicca [Jpn]. Folia Ophthalmology of Japan 1990, 50:536-539.
27. Berntsen D.A., Mitchell L., Nichols J.J. Reliability of grading lissamine green conjunctival staining. Cornea 2006, 25:695-700.
28. Korb D.R., Herman J.P., Finnemore V.M., Exford J.M., Blackie C.A. An evaluation of the efficiacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining. Eye Contact Lens 2008, 34:61-64.
29. Machado L.M., Castro R.S., Fontes B.M. Staining patterns in dry eye syndrome: Rose Bengal versus lissamine green. Cornea 2009, 28:732-734.
30. Yoon K.-C., Im S.-K., Kim H.-G., You I.-C. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Cornea 2011, 30:972-976.
31. Marshall P.N. The composition of erythrosins, fluorescein, phloxine and rose bengal: a study using thin-layer chromatography and solvent extraction. Histochemical Journal 1976, 8:487-499.
32. Marx E. Über vitale Farbung des Auges und der Augenlider. I. Über Anatomie, Physiologie und Pathologie des Augenlidrandes und der Tranenpunkte. Graefes Archive for Ophthalmology 1924, 114:465-482.
33. De Haas E.B.H. Desiccation of cornea and conjunctiva after sensory denervation. Archives of Ophthalmology 1962, 67:439-452.
34. Norn M.S. Rose bengal vital staining. Staining of cornea and conjunctiva by 10% rose bengal, compared with 1%. Acta Ophthalmologica 1970, 48:546-559.
35. Stenstam T. On the occurrence of keratoconjunctivitis sicca in cases of rheumatoid arthristis. Acta Medica Scandinavica 1947, 127:130-148.
36. O'Day K. Bengal rose as an aid in the diagnosis of keratoconjunctivitis sicca (Sjogrens syndrome). Medical Journal of Australia 1951, 2:708-709.
37. Williamson J., Doig W.M., Forrester J.V., Tham M.H., Wilson T., Whaley K., et al. Management of the dry eye in Sjogren's syndrome. British Journal of Ophthalmology 1974, 58:798-805.
38. Van Bijsterveld O.P. Diagnostic tests in the sicca syndrome. Archives of Ophthalmology 1969, 82:10-14.
39. Tabery H.M. Corneal surface changes in keratoconjunctivitis sicca. Part 1. The surface proper. A noncontact photomicrographic in vivo study in the human cornea. Eye 2003, 17:482-487.
40. Török M. Hydroxypropylmethylhaltige Augentropfen in der Behandlung des "Sicca" Syndroms. Klin Monatsbl Augenheilkd 1985, 187:60-62.
41. Norn M.S. Vital staining of the cornea and conjunctiva. Acta Ophthalmologica 1962, 40:389-401.
42. Passmore J.W., King J.H. Vital staining of conjunctiva and cornea. Review of literature and critical study of certain dyes. Archives of Ophthalmology 1955, 53:568-574.
43. Lansche R.K. Vital staining in normal eyes and in keratoconjunctivitis sicca. American Journal of Ophthalmology 1965, 60:520-525.
44. Zuccaro V.S. Rose Bengal, a vital stain. Contact Lens Forum 1981, (October):39-43.
45. Slatter D.H. Differential vital staining of the cornea and conjunctiva with fluorescein-rose bengal and alcian blue. Journal of Small Animal Practice 1973, 14:291-296.
46. Forster H.W. Rose bengal test in diagnosis of deficient tear formation. Archives of Ophthalmology 1951, 45:419-424.
47. Moller P.M. Jod og Lacrilbehandling ved Keratoconjunctivitis Sicca 1952, vol. 114:278-280. Ugeskr. Laeger, Copenhn.
48. Flynn F., Schulmeister A. Keratoconjunctivitis sicca and new techniques in its management. Medical Journal of Australia 1967, 1:33-41.
49. Duarte Favaro R.M., De Souza N.V., Vannucchi H., Desai I.D., De Oliveira J.E. Evaluation of rose bengal staining test and rapid dark adaptation test for the field assessment of vitamin A status of preschool children in southern Brazil. American Journal of Clinical Nutrition 1985, 43:940-945.
50. Laroche R.R., Campbell R.C. Quantitative rose Bengal staining technique for external ocular diseases. Annals of Ophthalmology (Chic) 1988, 20:274-276.
51. Paschides C.A., Petroutsos G., Psilas K. Correlation of conjunctival impression cytology results with lacrimal function and age. Acta Ophthalmologica 1991, 69:422-425.
52. Josephson J.E., Caffery B.E., Tepperman C.L., Wong M. Rose bengal staining before and after anesthetic. Optometry & Vision Science 1990, 67:659-660.
53. Roncin S., Pennec Y.L., Katsikis P., Colin J., Youinou P. Ocular surface lesions due to keratoconjunctivitis sicca in primary Sjögren's syndrome. Documenta Ophthalmologica 1992, 79:277-284.
54. Bekibele C.O., Baiyeroju A.M., Jaiyeoba A.I., Akang E.E.U., Ajayi B.G.K. Tear function and abnormalities of ocular surface: Relationship with subjective symptoms of dry eye in Ibadan, Nigeria. Middle East Africa Journal of Ophthalmology 2008, 15:12-15.
55. Doughty M.J., Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants-a systematic review. Ophthalmic and Physiological Optics 2009, 29:573-583.
56. Caffery B., Simpson T., Wang S., Bailey D., McComb J., Rutka J., et al. Rose Bengal staining of the temporal conjunctiva differentiates Sjogren's syndrome from keratoconjunctivitis sicca. Investigative Ophthalmology & Visual Science 2010, 51:2381-2387.
57. Knezović I., Alajbeg I., Karlović D., Pavan J., Vrkić N., Biŝćan A. Differential diagnostic performance of rose Bengal score test in Sjögren's syndrome patients. Collegium Antropologicum 2011, 35:1105-1113.
58. Botsios C., Furlan A., Ostuni P., Sfiso P., Andretta M., Ometto F., et al. Elderly onset of primary Sjögren's syndrome: Clinical manifestations, serological features and oral/ocular diagnostsic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 2011, 78:171-174.
59. Uchino Y., Uchino M., Dogru M., Ward S., Yokoi N., Tsubota K. Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria. Japanese Journal of Ophthalmology 2012, 56:8-13.
60. Matsumoto Y., Ohashi Y., Watanabe H., Tsubota K. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Ophthalmology 2012, 119:1954-1960.
61. Takamura E., Tsubota K., Watanabe H., Ohashi Y. A randomized, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. British Journal of Ophthalmology 2012, 96:1310-1315.
62. Kamiya K., Nakanishi M., Ishii R., Kobashi H., Igarashi A., Sato N., et al. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective randomized, multicenter study. Eye 2012, 26:1363-1368.
63. Jacobi C., Kruse F.E., Cursiefen C. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye. Journal of Ocular Pharmacology and Therapeutics 2012, 28:598-603.
64. Doughty M.J. Morphological features of cells along Marx's line of the marginal conjunctiva of the human eyelid. Clinical and Experimental Optometry 2013, 96:76-84.
65. Chodosh J., Dix R.D., Howell R.C., Stroop W.G., Tseng S.C.G. Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B. Investigative Ophthalmology & Visual Science 1994, 35:1046-1058.
66. Kim J., Foulks G.N. Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. Cornea 1999, 18:328-332.
67. Klaassen-Broekema N., Mackor A.J., Van Bijsterveld OP The diagnostic power of tests for tear gland related keratoconjunctivitis sicca. Netherlands Journal of Medicine 1992, 40:113-116.
68. McCarty C.A., Bansal A.K., Livingstone P.M., Stanislavsky Y.L., Taylor H.R. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998, 105:1114-1119.
69. Jones B.C., Coop H.V. The management of keratoconjunctivitis sicca. Transactions of the Ophthalmological Societies of the United Kingdom 1965, 85:379-389.
70. Sullivan L.J., McCurrach F., Lee S., Taylor H.R., Rolando M., Marechal-Courtois C., et al. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Ophthalmology 1997, 104:1402-1408.
71. Holzchuh R., Villa Albers M.C., Oaki T.H., Igami T.Z., Santo R.M., Kara-Jose N., et al. Two-year outcome of partial lacrimal punctual occlusion in the management of dry eye related to Sjögren syndrome. Current Eye Research 2011, 36:507-512.
72. Toda I., Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea 1993, 12:366-367.
73. Nichols K.K., Nichols J.J., Mitchell G.L. The relation between tear film tests in patients with dry eye disease. Ophthalmic and Physiological Optics 2003, 23:553-560.
74. Viso E., Rodriguez-Ares M.T., Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (The Salnes Eye Study). Ophthalmic Epidemiology 2009, 16:15-21.
75. Ibrahim O.M.A., Dogru M., Kawashima S., Wakamatsu T.H., Tsubota K., Fujishima H. Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with Sjögren syndrome. Cornea 2013, 32:653-657.
76. Ibrahim O.M.A., Dogru M., Kojima T., Matsumoto Y., Wakamatsu T.H., Tsubota K., et al. OCT assessment of tear meniscus after punctual occlusion in dry eye disease. Optometry & Vision Science 2012, 89:E770-E776.
77. Whitcher J.P., Shiboski C.H., Shiboscki S.C., Heidenreich A.M., Kitagawa K., Zhang S., et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome international registry. American Journal of Ophthalmology 2010, 149:405-415.
78. Lemp M.A. Advances in understanding and managing dry eye disease. American Journal of Ophthalmology 2008, 146:350-356.
79. Darvall R. External ocular conditions associated with hormonal dysfunction. Transactions of the Ophthalmological Society of Australia 1957, 17:42-47.
80. Molemans M., Maudgal P.C., Missotten L. Hydroxypropylmethylcellulose in the treatment of dry eye. Bulletin of the Belgian Society of Ophthalmology 1982, 201:93-97.
81. Deschamps F., Royer J., Montard M., Roth A., Andermann C. Essai en double aveugle de larmes artificielles naturelles dans 33 cas de scheresses ocularires. Bulletin des sociétés d'ophtalmologie de France 1981, 81:827-832.
82. Donald C., Hamilton L., Doughty M.J. A quantitative assessment of the location and width of 'Marx's line; along the marginal zone of the human eyelid. Optometry & Vision Science 2003, 80:564-572.
83. Doughty M.J., Naase T., Donald C., Hamilton L., Button N.F. Visualization of 'Marx's Line' along the marginal eyelid conjunctiva of human subjects with lissamine green dye. Ophthalmic and Physiological Optics 2004, 24:1-7.
84. Golebiowski B., Chim K., So J., Jalbert I. Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms. Optometry & Vision Science 2012, 89:1443-1449.
85. Doughty M.J. Comparative anatomy and physiology of the cornea and conjunctiva. Ocular Surface 2012, 32-78. CRC Press, Boca Raton, FL, Chapter 3. R. Martin Herranz, R.M. Corrales (Eds.).
86. Holmberg B. On the permeability to lissamine green and other dyes in the course of cell injury and cell death. Experimental Cell Research 1961, 22:406-414.
87. Dry Eye Workshop The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocular Surface 2007, 5:75-92.
88. Dry Eye Workshop Management and therapy of dry eye disease. Ocular Surface 2007, 5:163-178.